Login / Signup

Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy.

Emanuele MondaMarta RubinoGiuseppe PalmieroFederica VerrilloMichele LioncinoGaetano DianaAnnapaola CirilloAdelaide FuscoFrancesca DongiglioMartina CaiazzaIppolita AltobelliAlfredo MaurielloNatale GuarnacciaAlessandra ScatteiaArturo CesaroGiuseppe PacileoBerardo SarubbiGiulia FrissoBarbara BauceAntonello D'AndreaSanto Delle GrottaglieMaria Giovanna RussoPaolo CalabròGiuseppe Limongelli
Published in: Journal of clinical medicine (2023)
The term arrhythmogenic cardiomyopathy (ACM) describes a large spectrum of myocardial diseases characterized by progressive fibrotic or fibrofatty replacement, which gives the substrate for the occurrence of ventricular tachyarrhythmias and the development of ventricular dysfunction. This condition may exclusively affect the left ventricle, leading to the introduction of the term arrhythmogenic left ventricular cardiomyopathy (ALVC). The clinical features of ALVC are progressive fibrotic replacement with the absence or mild dilation of the LV and the occurrence of ventricular arrhythmias within the left ventricle. In 2019, the diagnostic criteria for the diagnosis of ALVC, based on family history and clinical, electrocardiographic, and imaging features, have been proposed. However, since the significant clinical and imaging overlap with other cardiac diseases, genetic testing with the demonstration of a pathogenic variant in an ACM-related gene is required for diagnostic confirmation. In ALVC, the multimodality imaging approach comprises different imaging techniques, such as echocardiography, cardiac magnetic resonance, and cardiac nuclear imaging. It provides essential information for the diagnosis, differential diagnosis, sudden cardiac death risk stratification, and management purposes. This review aims to elucidate the current role of the different multimodality imaging techniques in patients with ALVC.
Keyphrases